The AHA provided a statement of record to the Senate Special Committee on Aging for a hearing Oct. 8 on the pharmaceutical and medical device supply chains. The AHA highlighted how many pharmaceutical products are imported and that many medical devices are manufactured overseas. “The low-margin nature of these products makes them difficult to produce within the U.S.,” the AHA wrote. “At the same time, disruption in the availability of these devices would curtail hospitals’ ability to perform life-saving surgeries and keep patients safe from contagion, as well as hinder providers’ ability to effectively diagnose, monitor and treat patients.”

The AHA encouraged the committee to pass legislation to help strengthen medical supply chains. The AHA earlier this year expressed support for the reintroduction of the Mapping America’s Pharmaceutical Supply Act (S. 1784), legislation that would create a plan for the Food and Drug Administration and the Department of Defense to map the U.S. pharmaceutical supply chain. Another AHA-supported bill, the Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (S. 2062), would award contracts to eligible generic-drug makers that would require them to maintain a six-month reserve of critical generic drugs and their active ingredients in case of shortages.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Nov. 14 released preliminary guidance to states on implementing provider tax provisions in the One Big…
Headline
The House is expected to begin a final vote Nov. 12 on the Senate-backed funding package, bringing a potential end to the government shutdown one step closer.…
Headline
The Senate Nov. 10 passed legislation to fund the federal government that will now head to the House for a vote as early as the evening of Nov. 12, as an end…
Headline
The Senate Nov. 9 took a critical first step toward ending the government shutdown as seven Democrats and Sen. Angus King, I-Maine, joined Republicans to…
Headline
Senate negotiations on a potential funding deal to end the record-long government shutdown are ongoing, and the chamber is likely to continue working through…
Headline
The AHA expressed support Nov. 3 for the bipartisan Home Health Stabilization Act (H.R. 5142), legislation that would establish a two-year pause on planned…